Company · CIK 0001130598 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Traws Pharma, Inc. · TRAW
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 AForm 4 → | Jul 16, 12:39 pm EDT | Charles David PauzaChief Science Officer Virology | 97,000 | — | — | 97,000 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 15, 9:32 pm EDT | Werner CautreelsDirector | 14,150 | — | — | 14,150 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 15, 4:32 pm EDT | Nikolay SavchukChief Operating Officer, Director | 93,000 | — | — | 93,000 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 9:57 pm EDT | Jack E StoverDirector | 14,150 | — | — | 14,150 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 8:26 pm EDT | Iain D. DukesChief Executive Officer, Director | 274,000 | — | — | 274,000 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 8:23 pm EDT | Robert RedfieldChief Medical Officer | 84,000 | — | — | 84,000 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 8:22 pm EDT | Charles Nolan ParkerChief Financial Officer | 90,000 | — | — | 90,000 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 8:22 pm EDT | Mary Teresa ShoemakerDirector | 14,150 | — | — | 14,150 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 8:21 pm EDT | Trafford ClarkeDirector | 14,150 | — | — | 14,150 | — | late |
| Jul 9, 2026 AForm 4 → | Jul 14, 8:19 pm EDT | John Harold LeamanDirector | 14,150 | — | — | 14,150 | — | late |